Amy L. Burroughs, Chief Executive Officer at Terns Pharmaceuticals, Inc. (TERN), bought 30,900 shares at $7.15 ($221K) on 2024-12-05, disclosed to the SEC on 2024-12-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.15 | 15,450 | $110K | 50.0% |
| 2 | $7.15 | 15,450 | $110K | 50.0% |
| Total | $7.15 avg | 30,900 | $221K | 100% |
| Filing → |
| TERN | SELL | 2026-01-16 | $5.1M | — | Filing → |
| TERN | SELL | 2026-01-06 | $5.4M | — | Filing → |
| TERN | BUY | 2025-06-25 | $180K | — | Filing → |